Xi Rao

Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models

First-in-human phase I/II safety and preliminary efficacy of PM1032, a bispecific antibody targeting CLDN18.2 and 4-1BB, in patients with advanced solid tumors.

Phase 1 study of ZV0203, a first in class pertuzumab ADC, in patients with HER2 positive advanced solid tumors.

Adding a PPARα Agonist Enhances T Cell-Mediated Effects of RT in Combination with Anti-PD-1

Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING

Phase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomes

[The relationship between serum HBV pgRNA and antigen status in patients with chronic hepatitis B after long-term nucleotide analogues treatment].

<scp>N⁶</scp>‐methyladenosine modification of circular <scp>RNA circ‐ARL3</scp> facilitates <scp>Hepatitis B virus</scp>‐associated hepatocellular carcinoma via sponging <scp>miR</scp>‐1305

Rab5a activates IRS1 to coordinate IGF-AKT-mTOR signaling and myoblast differentiation during muscle regeneration

&lt;p&gt;KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA&lt;/p&gt;